Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of dolastatin 10 in treating patients who have
recurrent or metastatic soft tissue sarcoma. Drugs used in chemotherapy use different ways to
stop tumor cells from dividing so they stop growing or die.